{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:58:38Z","timestamp":1790423918879,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prro.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:29:01Z","timestamp":1788622141000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Moderately Hypofractionated Regional Nodal Irradiation in Breast Cancer: Final Results of a Prospective Clinical Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2217-8477","authenticated-orcid":false,"given":"Jacob F.","family":"Oyeniyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha S.","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Riutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-0897","authenticated-orcid":false,"given":"Joshua T.","family":"Dilworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.08.008_bib0001","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2026.08.008_bib0002","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.08.008_bib0003","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2026.08.008_bib0004","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2026.08.008_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.08.008_bib0006","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2414859","article-title":"Omitting regional nodal irradiation after response to neoadjuvant chemotherapy","volume":"392","author":"Mamounas","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.08.008_bib0007","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.08.008_bib0009","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Breast Cancer","year":"2026"},{"key":"10.1016\/j.prro.2026.08.008_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0011","article-title":"Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries","volume":"8","author":"Kraus","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0012","article-title":"Challenges and opportunities with the use of hypofractionated radiation therapy in cancer care: Regional perspectives from South Korea, Japan, Singapore, and Australia","volume":"8","author":"Akimoto","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0013","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.57187\/s.3464","article-title":"A comparative cost analysis of 25-fraction vs 5-fraction postoperative radiotherapy regimens for breast cancer","volume":"155","author":"Aliaj","year":"2025","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.prro.2026.08.008_bib0014","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","article-title":"Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials","volume":"126","author":"Haviland","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0016","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: First results from a prospective phase II trial","volume":"35","author":"Khan","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1202544","article-title":"A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis","volume":"13","author":"Gil","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0018","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2020.03.020","article-title":"5-year update of a multi-institution, prospective phase 2 hypofractionated postmastectomy radiation therapy trial","volume":"107","author":"Poppe","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.08.008_bib0019","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.prro.2025.03.014","article-title":"The efficacy and toxicity of hypofractionated regional nodal irradiation in breast cancer patients","volume":"15","author":"Spiegel","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ijrobp.2024.04.014","article-title":"Toxicity evaluation of dose-escalation in hypofractionated regional nodal irradiation for breast cancer: A retrospective study","volume":"120","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.08.008_bib0021","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: A randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110849","article-title":"Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial","volume":"207","author":"Brion","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0023","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(25)02597-8","article-title":"5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): A French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial","volume":"407","author":"Rivera","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2026.08.008_bib0024","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1200\/JCO-25-01747","article-title":"Postmastectomy radiation therapy: An ASTRO-ASCO-SSO clinical practice guideline","volume":"43","author":"Jimenez","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.prro.2025.05.001","article-title":"Postmastectomy radiation therapy: An ASTRO\/ASCO\/SSO clinical practice guideline","volume":"15","author":"Jimenez","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0026","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0027","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1756-9966-32-88","article-title":"Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer","volume":"32","author":"Bruzzaniti","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.prro.2026.08.008_bib0028","first-page":"895","article-title":"Leveraging technology and standardized institutional practices to mitigate disparities in breast cancer radiation therapy","volume":"36","author":"Oyeniyi","year":"2025","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.prro.2026.08.008_bib0029","unstructured":"Radiation Therapy Oncology Group. NRG Oncology Breast Atlas. NRG Oncology. Accessed January 1, 2026.https:\/\/nrgoncology.org\/wp-content\/uploads\/2025\/09\/RADCOMP-Breast-Atlas-v.3-bigreduced.pdf"},{"key":"10.1016\/j.prro.2026.08.008_bib0030","series-title":"Breast Cancer Atlas for Radiation Therapy Planning: Consensus Definitions","year":"2016"},{"key":"10.1016\/j.prro.2026.08.008_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.meddos.2025.03.005","article-title":"Optimizing posterior neck coverage in regional nodal irradiation for breast cancer","volume":"50","author":"Oyeniyi","year":"2025","journal-title":"Med Dosim"},{"key":"10.1016\/j.prro.2026.08.008_bib0032","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: Long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0033","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2026.08.008_bib0034","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0035","series-title":"Breast Cancer","first-page":"63","article-title":"Measuring breast cancer-related lymphedema","author":"Mayrovitz","year":"2022"},{"key":"10.1016\/j.prro.2026.08.008_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4274\/ejbh.galenos.2024.2023-12-8","article-title":"Comparison of volume measurements and bioimpedance spectroscopy using a stand-on device for assessment of unilateral breast cancer-related lymphedema","volume":"20","author":"Ward","year":"2024","journal-title":"Eur J Breast Health"},{"key":"10.1016\/j.prro.2026.08.008_bib0037","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1245\/s10434-021-10645-3","article-title":"Diagnostic criteria for breast cancer-related lymphedema of the upper extremity: The need for universal agreement","volume":"29","author":"Kassamani","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0038","doi-asserted-by":"crossref","first-page":"S4430","DOI":"10.1016\/S0167-8140(25)04203-3","article-title":"5027 DBCG Skagen trial 1: Phase III randomised trial of hypo- vs standard fractionated loco-regional radiotherapy in node-positive breast cancer patients","volume":"206","author":"Offersen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0039","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jamaoncol.2024.2652","article-title":"Hypofractionated vs conventionally fractionated postmastectomy radiation after implant-based reconstruction: A randomized clinical trial","volume":"10","author":"Wong","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2026.08.008_bib0040","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ijrobp.2024.07.002","article-title":"A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505)","volume":"120","author":"Poppe","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.08.008_bib0041","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2021.08.026","article-title":"Contemporary outcomes after multimodality therapy in patients with breast cancer presenting with ipsilateral supraclavicular node involvement","volume":"112","author":"Diao","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.08.008_bib0042","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijrobp.2022.02.037","article-title":"Locoregional management and prognostic factors in breast cancer with ipsilateral internal mammary and axillary lymph node involvement","volume":"113","author":"Andring","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:16:07Z","timestamp":1790421367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S1879850026002729"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.08.008","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderately Hypofractionated Regional Nodal Irradiation in Breast Cancer: Final Results of a Prospective Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}